Also categorized in Health Technology:
The first U.S. trials in people put CRISPR to the test in 2019
x hide permanently

Genome-Wide CRISPR Screening Used to Identify Factors Essential for SARS-CoV-2 Infection in Humans

Medical News

In a methodologically trailblazing paper published in the journal Nature Genetics, a team of Belgian scientists uncovered an assembly of coronavirus host factors that may be exploited to develop drugs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also potentially forthcoming zoonotic coronaviruses.

The coronavirus disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, has resulted in a global health and economic crisis; however, while vaccines are now being used around the world, only a handful of effective drugs are currently available to treat patients with the disease.

Albeit remdesivir was initially viewed as a promising candidate for ...